Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck and Ridgeback initiate Covid-19 trial of oral antiviral therapeutic
The MOVe-AHEAD study will evaluate the efficacy and safety of molnupiravir in preventing the spread of the SARS-CoV-2 virus. Credit: Pete Linforth from Pixabay.
The MOVe-AHEAD study will evaluate the efficacy and safety of molnupiravir in preventing the spread of the SARS-CoV-2 virus. Credit: Pete Linforth from Pixabay.